Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Arginine inactivates human herpesvirus 2 and inhibits genital herpesvirus infection.

Ikeda K, Yamasaki H, Minami S, Suzuki Y, Tsujimoto K, Sekino Y, Irie H, Arakawa T, Koyama AH.

Int J Mol Med. 2012 Dec;30(6):1307-12. doi: 10.3892/ijmm.2012.1149. Epub 2012 Oct 4.

PMID:
23042569
2.

Solvent-induced virus inactivation by acidic arginine solution.

Tsujimoto K, Uozaki M, Ikeda K, Yamazaki H, Utsunomiya H, Ichinose M, Koyama AH, Arakawa T.

Int J Mol Med. 2010 Mar;25(3):433-7.

PMID:
20127049
3.

In vivo evaluation of antiviral efficacy against genital herpes using mouse and guinea pig models.

Valencia F, Veselenak RL, Bourne N.

Methods Mol Biol. 2013;1030:315-26. doi: 10.1007/978-1-62703-484-5_24.

PMID:
23821278
4.

Effects of electrolytes on virus inactivation by acidic solutions.

Nishide M, Tsujimoto K, Uozaki M, Ikeda K, Yamasaki H, Koyama AH, Arakawa T.

Int J Mol Med. 2011 Jun;27(6):803-9. doi: 10.3892/ijmm.2011.668. Epub 2011 Apr 4.

PMID:
21468540
5.

Co-operative thermal inactivation of herpes simplex virus and influenza virus by arginine and NaCl.

Utsunomiya H, Ichinose M, Tsujimoto K, Katsuyama Y, Yamasaki H, Koyama AH, Ejima D, Arakawa T.

Int J Pharm. 2009 Jan 21;366(1-2):99-102. doi: 10.1016/j.ijpharm.2008.09.012. Epub 2008 Sep 18.

PMID:
18845231
6.

Antiviral effect of arginine against herpes simplex virus type 1.

Naito T, Irie H, Tsujimoto K, Ikeda K, Arakawa T, Koyama AH.

Int J Mol Med. 2009 Apr;23(4):495-9.

PMID:
19288025
7.

Effect of ASP2151, a herpesvirus helicase-primase inhibitor, in a guinea pig model of genital herpes.

Katsumata K, Chono K, Sudo K, Shimizu Y, Kontani T, Suzuki H.

Molecules. 2011 Aug 25;16(9):7210-23. doi: 10.3390/molecules16097210.

8.

Geldanamycin, a ligand of heat shock protein 90, inhibits herpes simplex virus type 2 replication both in vitro and in vivo.

Li YH, Lu QN, Wang HQ, Tao PZ, Jiang JD.

J Antibiot (Tokyo). 2012 Oct;65(10):509-12. doi: 10.1038/ja.2012.67. Epub 2012 Aug 22.

PMID:
22909975
10.

Isolation of sulfated galactan from Codium fragile and its antiviral effect.

Ohta Y, Lee JB, Hayashi K, Hayashi T.

Biol Pharm Bull. 2009 May;32(5):892-8.

11.

Protective effect of a natural carrageenan on genital herpes simplex virus infection in mice.

Carlucci MJ, Scolaro LA, Noseda MD, Cerezo AS, Damonte EB.

Antiviral Res. 2004 Nov;64(2):137-41.

PMID:
15498610
12.

Butyroyl-arginine as a potent virus inactivation agent.

Katsuyama Y, Yamasaki H, Tsujimoto K, Koyama AH, Ejima D, Arakawa T.

Int J Pharm. 2008 Sep 1;361(1-2):92-8. doi: 10.1016/j.ijpharm.2008.05.020. Epub 2008 May 27.

PMID:
18617337
13.

An improved system for the evaluation of antiviral compounds against herpes simplex virus type 2.

Yin S, Li Y, Xia H, Zhao J, Zhang Z, Tang S, Kou Z, Chen J, Yu J, Fan Z, Li T.

J Virol Methods. 2013 May;189(2):317-20. doi: 10.1016/j.jviromet.2013.02.006. Epub 2013 Feb 27.

PMID:
23454799
14.

Activity of two synthetic amphiphilic peptides and magainin-2 against herpes simplex virus types 1 and 2.

Aboudy Y, Mendelson E, Shalit I, Bessalle R, Fridkin M.

Int J Pept Protein Res. 1994 Jun;43(6):573-82.

PMID:
7928088
16.

Therapeutic effect of meliacine, an antiviral derived from Melia azedarach L., in mice genital herpetic infection.

Petrera E, Coto CE.

Phytother Res. 2009 Dec;23(12):1771-7. doi: 10.1002/ptr.2850.

PMID:
19441066
17.

Vaccination against bovine herpes mammillitis virus infections in guinea pigs.

Smee DF, Leonhardt JA.

Intervirology. 1994;37(1):20-4.

PMID:
7928285
18.
19.
20.

Inhibition of herpes simplex virus type 2 by vaginal lactobacilli.

Conti C, Malacrino C, Mastromarino P.

J Physiol Pharmacol. 2009 Dec;60 Suppl 6:19-26.

Supplemental Content

Support Center